PainQx
PainQx provides objective, quantitative pain assessments to help clinicians measure and manage patient pain. The platform analyzes electroencephalographic (EEG) signals with proprietary AI/ML algorithms to produce a scaled pain biomarker correlated to a patient’s pain state and neurological side effects. PainQx operates as an AI-powered medical device and cloud-based platform offered via subscription or pay-per-use to healthcare customers. Its primary use cases include clinical assessment in trials, emergency and pain clinics, and evaluating patients who cannot reliably self-report pain.
PainQx
PainQx provides objective, quantitative pain assessments to help clinicians measure and manage patient pain. The platform analyzes electroencephalographic (EEG) signals with proprietary AI/ML algorithms to produce a scaled pain biomarker correlated to a patient’s pain state and neurological side effects. PainQx operates as an AI-powered medical device and cloud-based platform offered via subscription or pay-per-use to healthcare customers. Its primary use cases include clinical assessment in trials, emergency and pain clinics, and evaluating patients who cannot reliably self-report pain.
TL;DR
What they do: AI-powered EEG platform producing an objective pain biomarker (ALGOS System) for clinical assessment and trials
Founded: 2015
HQ / Location: New York, NY
Business model: Cloud-based processing delivered via subscription or pay-per-use
Recent funding signal: Seed round reported (~$740k, Apr 2021) and grant funding including The Military Health System
Company Overview
Problem Domain
Objective measurement and management of chronic pain; clinical endpoints for pain therapy research and drug trials.
Founded
2015
Industry
DeepTech
Tech Stack
Funding Track Record
$740,000
Seed round listed Apr 2021 in dealroom; reported amount ~ $740k
Grant funding recorded with The Military Health System as lead funder
Investor Signal
“AJI Capital; Accelerate New York Seed Fund; Arizona Tech Investors; Italian Angels for Growth; Keiretsu Capital; MassChallenge; Mid Atlantic Bio Angels; NYU Innovation Venture Fund; New York Angels; Newchip Accelerator; The Military Health System; ic@3401”